What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction?

[1]  A. Minervini,et al.  Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic , 2020, European Urology Focus.

[2]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[3]  Yuhong Yuan,et al.  Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis. , 2019, European urology.

[4]  M. Kattan,et al.  Guidelines for Reporting of Statistics for Clinical Research in Urology. , 2019, European urology.

[5]  Yuhong Yuan,et al.  Key Steps in Conducting Systematic Reviews for Underpinning Clinical Practice Guidelines: Methodology of the European Association of Urology. , 2018, European urology.

[6]  P. Williamson,et al.  A core outcome set for localised prostate cancer effectiveness trials , 2017, BJU international.

[7]  A. Tubaro,et al.  Can Long-term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? , 2017, Current Urology Reports.

[8]  Angus G K McNair,et al.  The COMET Handbook: version 1.0 , 2017, Trials.

[9]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[10]  G. Guyatt,et al.  Minimally important difference estimates and methods: a protocol , 2015, BMJ Open.

[11]  Alexander Bachmann,et al.  A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. , 2015, European Urology.

[12]  P. Abrams,et al.  Transurethral resection of the prostate for benign prostatic obstruction: will it remain the gold standard? , 2015, European urology.

[13]  C. Mamoulakis.  A plea for higher-quality data for GreenLight laser technology in the context of surgical benign prostatic obstruction trials: the GOLIATH study-fact or fiction in the era of evidence-based urology? , 2014, European urology.

[14]  S. Maclennan,et al.  Systematic review and meta‐analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP) , 2014, BJU international.

[15]  E. Vicaut,et al.  Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study. , 2013, European urology.

[16]  J. J. de la Rosette,et al.  Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. , 2009, European urology.

[17]  T. Lancet.  Surgical research: the reality and the IDEAL , 2009, The Lancet.

[18]  R. Hays,et al.  Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. , 2008, Journal of clinical epidemiology.

[19]  C. Bouza,et al.  Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia , 2006, BMC urology.

[20]  M. Holmes,et al.  Transurethral needle ablation of the prostate: outcome at 1 year. , 1999, Journal of endourology.

[21]  M. Barry,et al.  Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? , 1995, The Journal of urology.

[22]  C. Charig,et al.  Balloon dilatation of the prostate: technique and early results. , 1990, British journal of urology.

[23]  N. Wasserman,et al.  Balloon dilatation of the prostate for treatment of benign hyperplasia. , 1988, The Urologic clinics of North America.

[24]  S. Kaplan.  Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? , 2018, The Journal of urology.

[25]  C. Gratzke,et al.  Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) , 2019 .

[26]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[27]  A. Zlotta,et al.  Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience. , 1995, Urology.